Perbedaan Phapros Tbk. dan Solusi Bangun Indonesia Tbk.: Phapros Tbk. diperdagangkan di Rp298 (kapitalisasi pasar 250,32 M, volume 24 jam 116,6 rb), sedangkan Solusi Bangun Indonesia Tbk. diperdagangkan di Rp775 (kapitalisasi pasar 6,99 T). Perbedaan utamanya: Solusi Bangun Indonesia Tbk. jauh lebih besar — sekitar 27,9× kapitalisasi pasar Phapros Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PEHA | SMCB | |
|---|---|---|
Kapitalisasi Pasar | 250,32 M | 6,99 T |
Volume | 116,6 rb | — |
Lot | 1,17 rb | — |
Perputaran | 34,22 jt | — |
Harga Rata-rata | 293,45 | — |
Nilai Transaksi | 34,22 jt | — |
Harga Ekuilibrium Indikatif | 300 | — |
Volume Ekuilibrium Indikatif | 7 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Selengkapnya di halaman PEHA →PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.
Selengkapnya di halaman SMCB →